Estados financieros detallados de Soligenix, Inc. (SNGX): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Márgenes de los últimos 12 meses: margen bruto 0.0%, margen operativo 0.0%, margen neto 0.0%.
Al precio actual de $0.36, SNGX presenta beneficios negativos (P/E no significativo) y un ROE del -181.02%. La capitalización bursátil es de $5M.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | $10.4M | $5.4M | $5.2M | $3.2M | $1.9M | $33351 | $250000 | 0 | 0 | 0 |
| Coste de Ventas | $8.4M | $4.3M | $4.6M | $3.6M | $1.8M | $728640 | $550822 | $742048 | $119371 | 0 |
| Beneficio Bruto | $2.0M | $1.1M | $643733 | -$351776 | $109584 | -$695289 | -$300822 | -$742048 | -$119371 | 0 |
| I+D | $4.3M | $5.5M | $6.8M | $8.1M | $14.8M | $8.2M | $7.9M | $3.3M | $5.2M | $7.5M |
| Generales y Administrativos | $3.4M | $3.2M | $3.0M | $3.5M | $4.3M | $5.0M | $6.7M | $4.5M | $4.2M | $4.4M |
| Gastos Operativos | $7.7M | $8.0M | $8.4M | $10.2M | $18.7M | $12.4M | $13.9M | $7.0M | $9.3M | $11.8M |
| Beneficio Operativo | -$5.7M | -$7.6M | -$9.1M | -$10.5M | -$18.6M | -$13.1M | -$14.2M | -$7.7M | -$9.4M | -$11.8M |
| EBITDA | -$5.6M | -$7.5M | -$9.0M | -$10.1M | -$18.5M | -$12.5M | -$14.1M | -$7.7M | -$9.5M | -$11.6M |
| Gastos por Intereses | 0 | 0 | 0 | 0 | $10882 | $904502 | $822611 | $49129 | 0 | 0 |
| Beneficio Antes de Impuestos | -$3.8M | -$7.6M | -$8.9M | -$10.0M | -$18.5M | -$13.4M | -$15.0M | -$7.9M | -$8.7M | -$11.6M |
| Impuestos | -$530000 | -$417000 | 0 | -$610676 | -$836893 | -$864742 | -$1.2M | -$1.8M | -$409114 | -$506615 |
| Beneficio Neto | -$3.2M | -$7.1M | -$8.9M | -$9.4M | -$17.7M | -$12.6M | -$13.8M | -$6.1M | -$8.3M | -$11.1M |
| BPA | $-223.20 | $-278.40 | $-162.09 | $-115.88 | $-154.45 | $-67.54 | $-76.96 | $-12.66 | $-4.98 | $-2.14 |
| BPA Diluido | $-321.60 | $-278.40 | $-162.09 | $-115.88 | $-154.45 | $-75.06 | $-76.89 | $-12.66 | $-4.98 | $-2.14 |
| Acciones en Circulación (Diluidas) | $14932 | $25601 | $54909 | $80735 | $114529 | $185797 | $179459 | $484877 | $1.7M | $5.2M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | 0 | 0 | 0 | 0 |
| Beneficio Bruto | 0 | -$1000 | -$1098 | 0 |
| Beneficio Operativo | -$2.6M | -$3.5M | -$2.9M | -$2.1M |
| EBITDA | -$2.5M | -$3.4M | -$2.8M | -$2.2M |
| Beneficio Neto | -$2.5M | -$2.9M | -$2.8M | -$2.0M |
| BPA | $-0.58 | $-0.29 | $-0.28 | $-0.12 |
| BPA Diluido | $-0.58 | $-0.29 | $-0.28 | $-0.12 |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $8.8M | $7.8M | $9.0M | $5.4M | $18.7M | $26.0M | $13.4M | $8.4M | $7.8M | $7.9M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cuentas por Cobrar | $1.2M | $1.3M | $1.2M | $1.5M | $564870 | $242721 | $219328 | $195148 | 0 | 0 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $10.1M | $9.4M | $10.3M | $7.5M | $19.5M | $26.6M | $13.9M | $9.5M | $8.8M | $8.8M |
| Inmovilizado Material | $26702 | $37163 | $19634 | $161505 | $251537 | $128375 | $359468 | $241761 | $115076 | $354965 |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | $126628 | $73952 | $46863 | $19699 | $23250 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $10.3M | $9.5M | $10.5M | $7.8M | $19.9M | $26.9M | $14.3M | $9.8M | $9.0M | $9.2M |
| Cuentas por Pagar | $1.7M | $1.8M | $2.1M | $2.7M | $2.1M | $2.9M | $3.9M | $1.1M | $667896 | $1.1M |
| Deuda a Corto | 0 | 0 | 0 | 0 | $324979 | 0 | $9.9M | $2.2M | $1.4M | 0 |
| Pasivos Corrientes | $2.9M | $3.2M | $4.2M | $6.3M | $6.1M | $6.3M | $16.5M | $6.2M | $4.8M | $3.7M |
| Deuda a Largo | 0 | 0 | 0 | 0 | $10.0M | $9.9M | 0 | $1.0M | 0 | 0 |
| Pasivos Totales | $2.9M | $3.2M | $4.2M | $6.3M | $16.1M | $16.1M | $16.8M | $7.3M | $4.8M | $3.9M |
| Reservas | -$150.1M | -$157.3M | -$166.2M | -$175.5M | -$193.2M | -$205.8M | -$219.6M | -$225.7M | -$234.0M | -$245.1M |
| Patrimonio Neto | $7.4M | $6.3M | $6.3M | $1.5M | $3.7M | $10.7M | -$2.5M | $2.5M | $4.1M | $5.3M |
| Deuda Total | 0 | 0 | 0 | $127224 | $10.5M | $10.0M | $10.2M | $3.5M | $1.5M | $358144 |
| Deuda Neta | -$8.8M | -$7.8M | -$9.0M | -$5.3M | -$8.2M | -$16.1M | -$3.1M | -$5.0M | -$6.3M | -$7.6M |
| Capital Circulante | $7.2M | $6.2M | $6.1M | $1.2M | $13.4M | $20.3M | -$2.7M | $3.4M | $4.0M | $5.1M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $10.5M | $7.9M | $6.0M | $9.8M |
| Activos Totales | $11.3M | $9.2M | $6.9M | $10.5M |
| Pasivos Totales | $3.7M | $3.9M | $3.8M | $3.9M |
| Patrimonio Neto | $7.6M | $5.3M | $3.1M | $6.6M |
| Deuda Total | $385054 | $358144 | $330660 | $302589 |
Flujo de Caja (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$3.2M | -$7.1M | -$8.9M | -$9.4M | -$17.7M | -$12.6M | -$13.8M | -$6.1M | -$8.3M | -$11.1M |
| Amortizaciones | $89928 | $68563 | $44060 | $54450 | $62372 | $34161 | $24562 | $6554 | $5814 | $3224 |
| Compensación en Acciones | $574977 | $489787 | $380886 | $376339 | $409933 | $361559 | $333389 | $370182 | $329815 | $587583 |
| Cambio en Capital Circulante | -$529884 | $72241 | $1.2M | $1.1M | $509307 | $651501 | $425112 | -$3.4M | -$348409 | $31818 |
| Flujo de Caja Operativo | -$5.0M | -$6.5M | -$7.2M | -$7.5M | -$11.5M | -$11.7M | -$12.6M | -$8.6M | -$8.4M | -$10.3M |
| Inversiones (CapEx) | -$7159 | -$26348 | -$1925 | -$30209 | -$7147 | -$11789 | -$13073 | 0 | 0 | -$5883 |
| Adquisiciones | 0 | 0 | $1000 | $5500 | 0 | 0 | 0 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$5.0M | -$6.5M | -$7.2M | -$7.5M | -$11.5M | -$11.8M | -$12.7M | -$8.6M | -$8.4M | -$10.3M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | -$2.9M | -$2.7M | -$2.4M | -$1.7M |
| Inversiones (CapEx) | -$608 | $3925 | $3 | 0 |
| Flujo de Caja Libre | -$2.9M | -$2.7M | -$2.4M | -$1.7M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $104346 | $320125 | 0 | 0 |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Ingresos (anual) | | -48.0% | -3.5% | -38.6% | -40.0% | -98.3% | +649.6% | -100.0% | | |
| Crecimiento Beneficio Neto (anual) | | -120.2% | -24.5% | -5.1% | -89.1% | +29.0% | -9.9% | +55.5% | -34.6% | -34.0% |
| Crecimiento BPA (anual) | | -24.7% | +41.8% | +28.5% | -33.3% | +56.3% | -13.9% | +83.5% | +60.7% | +57.0% |
| Cambio en Acciones (anual) | | +71.5% | +114.5% | +47.0% | +41.9% | +62.2% | -3.4% | +170.2% | +242.4% | +212.6% |
| Crecimiento FCF (anual) | | -31.0% | -10.9% | -4.0% | -52.0% | -2.5% | -7.7% | +32.0% | +2.3% | -22.2% |
| Margen Bruto | 19.3% | 20.7% | 12.3% | -10.9% | 5.7% | -2084.8% | -120.3% | | | |
| Margen Operativo | -54.6% | -139.8% | -172.8% | -327.8% | -962.8% | -39276.1% | -5695.6% | | | |
| Margen EBITDA | -53.8% | -138.5% | -172.0% | -312.6% | -955.8% | -37411.3% | -5642.4% | | | |
| Margen Neto | -31.1% | -131.6% | -169.8% | -290.9% | -916.3% | -37633.0% | -5519.3% | | | |
| Margen FCF | -47.8% | -120.3% | -138.3% | -234.5% | -593.7% | -35235.6% | -5064.8% | | | |
| Tasa Impositiva Efectiva | 14.0% | 5.5% | -0.0% | 6.1% | 4.5% | 6.4% | 7.7% | 22.4% | 4.7% | 4.4% |
Datos por Acción (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $-334.15 | $-255.34 | $-131.97 | $-93.39 | $-100.08 | $-63.25 | $-70.56 | $-17.74 | $-5.06 | $-1.98 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $14506 | $25601 | $54909 | $80735 | $114529 | $185797 | $179292 | $484877 | $1.7M | $5.2M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -181.02% |
| Rentabilidad sobre capital invertido | -151.39% |
| Rentabilidad sobre activos | -97.52% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Salud financiera
| Deuda / Patrimonio | 0.05 |
| Ratio corriente | 2.77 |
| Piotroski F-Score | 2 |
| Altman Z-Score | -39.65 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -2.42 | -1.91 | -1.27 | -3.00 | -1.99 | -2.35 | -1.41 | -0.96 | -0.54 | -0.63 |
| P/VC | 1.06 | 2.16 | 1.80 | 19.28 | 9.40 | 2.75 | -7.87 | 2.33 | 1.09 | 1.31 |
| P/V | 0.75 | 2.51 | 2.16 | 8.74 | 18.22 | 882.83 | 77.80 | 0.00 | 0.00 | 0.00 |
| Margen Bruto | 19.3% | 20.7% | 12.3% | -10.9% | 5.7% | -2084.8% | -120.3% | 0.0% | 0.0% | 0.0% |
| Margen Operativo | -54.6% | -139.8% | -172.8% | -327.8% | -962.8% | -39276.1% | -5695.6% | 0.0% | 0.0% | 0.0% |
| Margen Neto | -31.1% | -131.6% | -169.8% | -290.9% | -916.3% | -37633.0% | -5519.3% | 0.0% | 0.0% | 0.0% |